देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
LEVONORGESTREL; ETHINYL ESTRADIOL
JAMP PHARMA CORPORATION
G03AA07
LEVONORGESTREL AND ESTROGEN
100MCG; 20MCG
TABLET
LEVONORGESTREL 100MCG; ETHINYL ESTRADIOL 20MCG
ORAL
15G/50G
Prescription
Active ingredient group (AIG) number: 0220415002; AHFS:
APPROVED
2022-10-21
PRODUCT MONOGRAPH Pr AUDRINA TM 21 AND Pr AUDRINA TM 28 Levonorgestrel and Ethinyl Estradiol Tablets, USP 100 mcg levonorgestrel and 20 mcg ethinyl estradiol tablets Oral Contraceptive JAMP Pharma Corporation 1310, rue Nobel Boucherville, Quebec J4B 5H3 DATE OF PREPARATION: October 20, 2022 SUBMISSION CONTROL NO: 232154 _Page 2 of 55_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ..................................................... 3 SUMMARY PRODUCT INFORMATION ....................................................................3 INDICATIONS AND CLINICAL USE..........................................................................3 CONTRAINDICATIONS..............................................................................................3 WARNINGS AND PRECAUTIONS .............................................................................4 ADVERSE REACTIONS ............................................................................................ 14 DRUG INTERACTIONS ............................................................................................ 21 DOSAGE AND ADMINISTRATION.......................................................................... 28 OVERDOSAGE.......................................................................................................... 32 ACTION AND CLINICAL PHARMACOLOGY ......................................................... 32 STORAGE AND STABILITY..................................................................................... 33 SPECIAL HANDLING INSTRUCTIONS ................................................................... 33 DOSAGE FORMS, COMPOSITION AND PACKAGING ........................................... 33 PART II: SCIENTIFIC INFORMATION.......................................................................... 34 CLINICAL TRIALS.................................................................................................... 35 DETAILED PHARMACOLOGY ................................................................................ 38 M पूरा दस्तावेज़ पढ़ें